75N91021C00013↗

Name: 75N91021C00013: Purpose: to Provide Clinical Trials Sponsor and Regulatory Management Support Services to the Nci, the Center for Cancer Research (CCR), and CCR Investigators.
Creator: SpendQuery
License: https://www.usa.gov/government-works

PURPOSE: TO PROVIDE CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.

Definitive Contract · National Institutes of Health · to Technical Resources International, Inc. (UEI FAA2LVENETH4) · data as of 2026-10-20

Obligated to date$45.33M7 actions

Current value$71.25Mwith options exercised

Potential value$115.52Mif every option is used

Period2021-07-01 → 2027-06-30up to 2031-06-30 with options

Up for re-bid: ends 2027-06-30. Recompete brief →

What it is

Product or service: Health R&D Services; Health Care Services; Basic Research (PSC AN11)
Industry: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office: Nih Nci (75N910)
Competition: Full and open after exclusion of sources · 2 offers received
Set-aside: Small business
Pricing: Cost plus fixed fee
How it was bought: Standalone contract
Solicitation: 75N91020R00027
Where the work is: Montgomery, MD · district MD-08

Obligations by fiscal year

FY2023$13.59M

FY2024$12.31M

FY2025$9.55M

FY2026$9.87M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

7 actions since 2023-06-15. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-07-23	P00011	Administrative change	$0	EO 14398 CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.
2026-06-24	P00010	Option exercised	$9.87M	CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.
2026-04-28	P00009	Administrative change	$0	EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CCR, AND CCR INVESTIGATORS
2025-07-01	P00008	Option exercised	$9.55M	EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CCR, AND CCR INVESTIGATORS
2025-04-11	P00007	Administrative change	$0	CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.
2024-06-28	P00006	Option exercised	$12.31M	CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.
2023-06-15	P00005	Option exercised	$13.59M	CLINICAL TRIALS SPONSOR AND REGULATORY MANAGEMENT SUPPORT SERVICES TO THE NCI, THE CENTER FOR CANCER RESEARCH (CCR), AND CCR INVESTIGATORS.

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-20). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…